Skip to Content

User Reviews for Genpril

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Learn more about Genpril.

Condition	Reviews	Compare	Avg. Ratings

Reviews for Genpril

No reviews have yet been submitted. Be the first to review this drug.

Learn more about

Micromedex® Care Notes:

More about Genpril (ibuprofen)

Consumer resources

Other brands: Advil, Motrin, IBU, Motrin IB, More (22) »

Professional resources

Related treatment guides

Drug Status

Availability Rx/OTC Rx and/or OTC

Pregnancy Category Multiple Risk depends on usage

CSA Schedule N Not a controlled drug

Ankylosing Spondylitis

FDA Consumer Updates

More FDA updates

Drug Class

Nonsteroidal anti-inflammatory agents

Recently Approved

Amjevita Amjevita (adalimumab-atto) is biosimilar to Humira, an anti-TNF-α monoclonal antibody approved for ...
Exondys 51 Exondys 51 (eteplirsen) is an antisense oligonucleotide indicated for the treatment of Duchenne...
Kyleena Kyleena (levonorgestrel-releasing intrauterine system) is a low-dose progestin-containing...
Yosprala Yosprala (aspirin and omeprazole) is a platelet aggregation inhibitor and proton pump inhibitor...

Related News and Articles

FDA Approves Amjevita (adalimumab-atto), a Biosimilar to Humira September 23, 2016
Arthritis Drug May Help With Type of Hair Loss September 22, 2016
Even at Cancer Centers, Finding Relief for Pain Can Be Tough September 20, 2016

Related Questions & Answers

How does the genpril help toothache?

Read more questions...

Drugs.com Discount Card

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Sep 2nd, 2016), Cerner Multum™ (updated Sep 5th, 2016), Wolters Kluwer™ (updated Aug 8th, 2016) and others. To view content sources and attributions, please refer to our editorial policy.